Sidekick Health Cracks the Code on Medication Adherence — Driving Better Outcomes and Lower Costs

NEW YORK, April 14, 2025 /PRNewswire/ — Medication non-adherence is a significant and preventable challenge in healthcare, contributing to an estimated 15% of all healthcare spending, or up to $300 billion annually. Patients skipping doses or abandoning treatments don’t just face worse health outcomes — they drive avoidable hospitalizations, complications, and increased costs for the healthcare ecosystem.

We’re making medication adherence effortless and scalable so patients stay healthier and costs are lower — for everyone.

Sidekick Health is tackling this problem head-on with an innovative, integrated approach for US payers: combining brand-specific medication adherence layers, developed with global pharmaceutical partners, with Sidekick’s digital-first, multi-condition care platform designed to deliver seamless, personalized, and scalable support with the goal to improve adherence — and cuts costs.

A Smarter Approach to Adherence

Sidekick’s new, integrated offering combines two of their flagship product categories into a single solution that unifies the patient experience into a single, seamless care journey and improves disease management for patients. And, it’s built to deliver better outcomes and lower healthcare costs for payers while offering greater adherence, persistence, and patient health outcomes for life sciences organizations:

  • Brand-Specific Adherence Developed in partnership with global pharmaceutical companies, these programs enhance adherence by providing patients with tailored education, reminders, and support tools for their specific medications and treatment plans.
  • Digital-First Multi-Condition Platform – This platform, spanning +20 chronic and episodic conditions — enables patients to manage multiple chronic conditions with a holistic, personalized approach to self-care and adherence, all in one, unified member experience.

“Even the best healthcare only works when patients stick with it,” said Travis Parkinson, President at Sidekick Health. “We’re making medication adherence effortless and scalable — so patients stay healthier, and costs are lower for all members of the healthcare ecosystem.”

Proven Results and Real-World Impact

Sidekick’s programs have demonstrated improved health outcomes for patients in preliminary clinical trials and studies across treatment areas, including: 7x greater reduction in HbA1c than standard care for type 2 diabetes, 40% reduction in diabetes-related stress, 50% improvement in shortness of breath for heart failure, and more.

“We’re redefining digital health’s role in patient care,” said Tryggvi Thorgeirsson, CEO at Sidekick Health. “This solution moves digital health forward to serve all of our stakeholders, from our patients to our partners.”

Learn more about Sidekick Health and our groundbreaking solution at  sidekickhealth.com/news.

Media Contact:

Manda Bertrand
+1 212 930 8555
press@sidekickhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/sidekick-health-cracks-the-code-on-medication-adherence–driving-better-outcomes-and-lower-costs-302426914.html

SOURCE Sidekick Health

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

16 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

16 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago